Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
The FEBS Journal
|
April 13, 2013
The anti-inflammatory compound BAY-11-7082 is a potent inhibitor of protein tyrosine phosphatases
Navasona Krishnan, Gyula Bencze, Philip Cohen, et al.
Current Medicinal Chemistry
|
June 13, 2009
Determination of human serum alpha1-acid glycoprotein and albumin binding of various marketed and preclinical kinase inhibitors
Ferenc Zsila, Ilona Fitos, Gyula Bencze, et al.
Journal of Chromatographic Science
|
September 19, 2013
HPLC analysis of carotenoids from tomatoes using cross-linked C18 column and MS detection
Hussein G Daood, Gyula Bencze, Gábor Palotás, et al.
Scientific Reports
|
August 27, 2020
Mito-oncology agent: fermented extract suppresses the Warburg effect, restores oxidative mitochondrial activity, and inhibits in vivo tumor growth
Gyula Bencze, Szilvia Bencze, Keith D Rivera, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Identification and Validation of an inhibitor of the protein kinases PIM and DYRK
Gyula Bencze, Prabhadevi Venkataramani, Elad Elkayam, et al.
Journal of Medicinal Chemistry
|
March 18, 2026
Identification and Validation of an Inhibitor of the Protein Kinases PIM and DYRK
Gyula Bencze, Prabhadevi Venkataramani, Elad Elkayam, et al.
Cell Reports
|
December 29, 2014
p53 mutations change phosphatidylinositol acyl chain composition
Adam Naguib, Gyula Bencze, Dannielle D Engle, et al.
Molecular Cell
|
April 14, 2015
PTEN functions by recruitment to cytoplasmic vesicles
Adam Naguib, Gyula Bencze, Hyejin Cho, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
The FEBS Journal
|
April 13, 2013
The anti-inflammatory compound BAY-11-7082 is a potent inhibitor of protein tyrosine phosphatases
Navasona Krishnan, Gyula Bencze, Philip Cohen, et al.
Current Medicinal Chemistry
|
June 13, 2009
Determination of human serum alpha1-acid glycoprotein and albumin binding of various marketed and preclinical kinase inhibitors
Ferenc Zsila, Ilona Fitos, Gyula Bencze, et al.
Journal of Chromatographic Science
|
September 19, 2013
HPLC analysis of carotenoids from tomatoes using cross-linked C18 column and MS detection
Hussein G Daood, Gyula Bencze, Gábor Palotás, et al.
Scientific Reports
|
August 27, 2020
Mito-oncology agent: fermented extract suppresses the Warburg effect, restores oxidative mitochondrial activity, and inhibits in vivo tumor growth
Gyula Bencze, Szilvia Bencze, Keith D Rivera, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Identification and Validation of an inhibitor of the protein kinases PIM and DYRK
Gyula Bencze, Prabhadevi Venkataramani, Elad Elkayam, et al.
Journal of Medicinal Chemistry
|
March 18, 2026
Identification and Validation of an Inhibitor of the Protein Kinases PIM and DYRK
Gyula Bencze, Prabhadevi Venkataramani, Elad Elkayam, et al.
Cell Reports
|
December 29, 2014
p53 mutations change phosphatidylinositol acyl chain composition
Adam Naguib, Gyula Bencze, Dannielle D Engle, et al.
Molecular Cell
|
April 14, 2015
PTEN functions by recruitment to cytoplasmic vesicles
Adam Naguib, Gyula Bencze, Hyejin Cho, et al.
Page
of 1